Search
forResearch 10 of 62
- Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions
- Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
Community 2
Learn
— no results
Try a deeper search in learn →